JITAI Smartphone App for Addiction

"Affirmative. According to the clinicaltrials.gov page, this research project is still open for recruitment and began on February 19th of 2020 with a most recent update in November 4th 2022. The study requires 185 subjects from 1 location."

"This clinical trial requires 185 participants with behavioural and substance addictions aged 18 to 75. Qualifying individuals must meet the following criteria: For outpatients, they need 35 enrollees between ages 18-75 that self-report physical opioid dependence as well as an interest in our treatment options. Those qualified for OBOT participation require positive urine screens or frank opioid withdrawal alongside age and treatment interests. Our Phase 2 microrandomization necessitates TE participants who are receiving methadone or buprenorphine from a certified provider within their community while also sharing an affinity for our treatments being tested during Phase 1 formative interviews."

"Affirmative. The relevant information available on clinicaltrials.gov indicates that this medical trial, which was first published on February 19th 2020, is actively recruiting participants. It requires 185 people to enroll from 1 centre in order to proceed with the study."

"By our estimation, JITAI's safety level is a 2 given the absence of clinical data in support of efficacy. Nonetheless, there is some evidence that suggests its security."

"As mandated by the guidelines of this particular trial, only patients aged 18 or older but under 75 are allowed to enrol."

"The primary measure of success in this JITAI trial will be its proximal effects. Secondary objectives include gauging the efficacy of push versus pull interventions, and investigating if trait variables such as personality or preferred coping styles influence responsiveness to CBT-based and ACT-based messages over an end of study time frame."